Asymptomatic Crohn's Disease Diagnosis and Management

Monitoring and Detection

The European Crohn's and Colitis Organisation recommends that patient symptoms and objective parameters of inflammation be monitored, as they can be disconnected in Crohn's disease, necessitating objective monitoring strategies 1
Inflammation often persists in the absence of gastrointestinal symptoms and may lead to progressive bowel damage and complications such as fistulae, abscesses, and strictures 1
Biomarkers like fecal calprotectin and C-reactive protein (CRP) may detect subclinical disease activity, though CRP has lower sensitivity and may be normal even during disease flares 2, 3
Patients with an unexpectedly raised CRP but no localizing symptoms should have fecal calprotectin measured to validate biochemical disease activity before arranging endoscopic evaluation 2

Capsule endoscopy has greater sensitivity for detecting mucosal small bowel Crohn's disease than radiological imaging techniques and can be performed when inflammatory small bowel disease is suspected despite normal cross-sectional imaging 4
Minor mucosal abnormalities found during capsule endoscopy can be seen in normal individuals (particularly those who have been using NSAIDs) and may be insufficient in isolation to diagnose Crohn's disease 4

Treatment goals in Crohn's disease are evolving beyond mere control of symptoms towards targeting sustained control of gastrointestinal inflammation to prevent bowel damage, reduce long-term disability, and maintain quality of life 1
The disconnect between symptoms and inflammation highlights the importance of objective disease monitoring, even in patients who appear asymptomatic 1

Relying solely on symptom assessment may lead to underdiagnosis or delayed diagnosis of Crohn's disease, as inflammation can be present without causing noticeable symptoms 1
When evaluating patients with suspected Crohn's disease but no symptoms, clinicians should be cautious about attributing minor endoscopic or radiologic findings to Crohn's disease, particularly if the patient has recently used NSAIDs 4